Boston Scientific EVP sells 35k shares: 3 notes

Michael Phalen, acting executive vice president and president-MedSurg of Boston Scientific, recently sold 35,000 shares of the firm, according to a Franklin Independent report.

Advertisement

Here are three notes:

1. The total transaction was valued at $770,000, at an average stock price per share of $22.

2. The highest price target for the stock is $26 and the lowest is $19.

3. The company has a market cap of $32.87 billion.

More articles on GI/endoscopy:
NY State Assemblyman introduces Upper Endoscopy Reform Act: 3 things to know
Certain mouth bacteria could help predict pancreatic cancer risk: 3 notes
Gastroenterologist Dr. Brian Levatino named 2016 Health Care Hero: 3 points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.